Roswell Park Cancer Institute /ID# 239128 — Buffalo, New York

Roswell Park Cancer Institute /ID# 239128 is a clinical research site located in Buffalo, New York, United States 14263.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Roswell Park Cancer Institute /ID# 239128 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Follicular Lymphoma (FL).

Sponsors: Genmab.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Roswell Park Cancer Institute /ID# 239128?

Roswell Park Cancer Institute /ID# 239128 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Roswell Park Cancer Institute /ID# 239128 conducted?

Roswell Park Cancer Institute /ID# 239128 has 1 clinical trials on record, with 1 currently active. Their work covers Follicular Lymphoma (FL).

Is Roswell Park Cancer Institute /ID# 239128 accredited by Crixeo Health?

Roswell Park Cancer Institute /ID# 239128 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Roswell Park Cancer Institute /ID# 239128?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.